Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

VitaNova Life Sciences (YJGJ) Return on Invested Capital (2024 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Return on Invested Capital for 2 consecutive years, with 0.46% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital rose 32.0% year-over-year to 0.46%, compared with a TTM value of 0.46% through Oct 2025, up 32.0%, and an annual FY2025 reading of 0.58%, up 30.0% over the prior year.
  • Return on Invested Capital was 0.46% for Q4 2025 at VitaNova Life Sciences, roughly flat from 0.46% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.55% in Q2 2025 and bottomed at 0.1% in Q3 2024.